Cyclophosphamide Injection Market

Cyclophosphamide injection is a cytotoxic drug used to treat malignant diseases in adults and children. Mainly used for malignant lymphoma, breast cancer, leukemia, metastatic or non-metastatic malignant solid tumors, progressive autoimmune diseases, immunosuppressive therapy during organ transplantation, childhood rhabdomyosarcoma and osteosarcoma, etc.
Cyclophosphamide Injection Market contains market size and forecasts of Cyclophosphamide Injection in global, including the following market information:
Global Cyclophosphamide Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cyclophosphamide Injection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cyclophosphamide Injection companies in 2021 (%)
The global Cyclophosphamide Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
High-Dose Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cyclophosphamide Injection include Baxter, Novartis, Amneal Pharmaceuticals, Aurobindo Pharma, Zydus Cadila, Pfizer, Athenex, GLS Pharma and NorthStar Rx LLC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cyclophosphamide Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cyclophosphamide Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cyclophosphamide Injection Market Segment Percentages, by Type, 2021 (%)
High-Dose
Low-Dose
Global Cyclophosphamide Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cyclophosphamide Injection Market Segment Percentages, by Application, 2021 (%)
Cancer
Autoimmune Diseases
AL Amyloidosis
Others
Global Cyclophosphamide Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cyclophosphamide Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cyclophosphamide Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cyclophosphamide Injection revenues share in global market, 2021 (%)
Key companies Cyclophosphamide Injection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cyclophosphamide Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter
Novartis
Amneal Pharmaceuticals
Aurobindo Pharma
Zydus Cadila
Pfizer
Athenex
GLS Pharma
NorthStar Rx LLC
Jiangsu Hengrui Medicine
Getwell Oncology
Ingenus